Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +39.32% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +34.35% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
Press releases
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 August 2024
- The Biotech Growth Trust PLC - Appointment of New Director
- The Biotech Growth Trust PLC - Blocklisting - Interim Review
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 July 2024
- The Biotech Growth Trust PLC - Result of General Meeting
- The Biotech Growth Trust PLC - Result of AGM
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 30 June 2024
More ▼
Key statistics
On Tuesday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,032.00, -3.40% below its 52-week high of 1,068.36, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 31.86m |
---|---|
Market cap | 336.44m GBP |
Total assets | 390.37m GBP |
Total expense ratio | 1.18% |
High | 1,058.00 |
Low | 1,032.00 |
Previous close | 1,056.00 |
Average volume | 110.28k |
---|---|
YTD Change | +15.44% |
Beta | 0.6315 |
Diluted NAV (est) | 1,093.99 |
Diluted NAV (last pub) | 1,102.79 |
Premium/Discount | -5.67% |
Net Gearing | +6.05% |
Data delayed at least 15 minutes, as of Oct 08 2024 16:35 BST.
More ▼